Stock 688131 SHANGHAI HAOYUAN CHEMEXPRESS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shanghai Haoyuan Chemexpress Co., Ltd.

Equities

688131

CNE1000051J4

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 15/05/2024 am IST 		5-day change 1st Jan Change
32.05 CNY -2.88% Intraday chart for Shanghai Haoyuan Chemexpress Co., Ltd. -9.26% -38.44%
29/04 Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
25/03 Haoyuan Chemexpress to Issue 822 Million Yuan Worth of Convertible Bonds MT

Business Summary

Shanghai Haoyuan Chemexpress Co Ltd is a China-based company mainly engaged in the research and development, production and sales of small molecule drugs. The Company's main products include molecular building blocks and tool compounds. The Company's products also include active pharmaceutical ingredients (APIs) and intermediates. The Company also provides related services such as contract research organization (CRO) service. The Company's molecular building blocks and tool compounds are applied in all stages of the drug discovery process. The Company distributes its products in domestic market and to overseas markets.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Molecular Building Blocks and Tool Compounds - Product
53.3 %
748 55.1 % 1,003 53.3 % +34.13%
Active Pharmaceutical Ingredient and Intermediate, Preparations - Product
23.0 %
390 28.8 % 432 23.0 % +10.69%
Active Pharmaceutical Ingredient and Intermediate, Preparations - Technical
16.2 %
131 9.6 % 304 16.2 % +132.51%
Molecular Building Blocks and Tool Compounds - Technical
6.9 %
79 5.8 % 129 6.9 % +62.81%
Other Business
0.6 %
10 0.7 % 12 0.6 % +19.63%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
63.0 %
889 65.9 % 1,177 63.0 % +32.43%
Overseas
37.0 %
460 34.1 % 691 37.0 % +50.46%

Managers

Managers TitleAgeSince
Qiang Gao FOU
 Founder 51 30/06/30
Bao Fu Zheng CEO
 Chief Executive Officer 45 30/06/30
Yu Chen Zhang CHM
 Chairman 56 01/20/01
Min Li DFI
 Director of Finance/CFO 43 01/09/01
Shuo Liang Li CTO
 Chief Tech/Sci/R&D Officer 47 23/15/23
Xian Shu Zhang BRD
 Director/Board Member 44 01/09/01
Hai Wang Liu BRD
 Director/Board Member 42 01/06/01
Fei Min Jin BRD
 Director/Board Member 58 01/16/01
Wen Jing Li IRC
 Investor Relations Contact 32 01/15/01
Wei Hong Shen SEC
 Corporate Secretary 38 01/08/01

Members of the board

Members of the board TitleAgeSince
Bin Yuan BRD
 Director/Board Member 43 20/19/20
Yun Chen BRD
 Director/Board Member 38 23/15/23
Bao Fu Zheng CEO
 Chief Executive Officer 45 30/06/30
Qiang Gao FOU
 Founder 51 30/06/30
Shuo Liang Li CTO
 Chief Tech/Sci/R&D Officer 47 23/15/23
Yao Gao BRD
 Director/Board Member 43 20/19/20
Xing Xian Zhang BRD
 Director/Board Member 51 20/19/20
Hai Wang Liu BRD
 Director/Board Member 42 01/06/01
Yu Chen Zhang CHM
 Chairman 56 01/20/01
Gu Xiao Dan BRD
 Director/Board Member 41 06/22/06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 150,387,339 62,305,471 ( 41.43 %) 0 41.43 %

Shareholders

NameEquities%Valuation
Shanghai Genuine Investment Management Co. Ltd.
4.932 %
4,262,588 4.932 % 20 M ¥
Zhong Ou Asset Management Co., Ltd
3.065 %
2,649,214 3.065 % 12 M ¥
Hwabao WP Fund Management Co., Ltd.
2.623 %
2,267,017 2.623 % 10 M ¥
Huashang Fund Management Co., Ltd.
1.941 %
1,677,177 1.941 % 8 M ¥
Golden Trust Sinopac Fund Management Co., Ltd.
1.833 %
1,583,833 1.833 % 7 M ¥
China Fund Management Co., Ltd.
1.157 %
1,000,000 1.157 % 5 M ¥
Rongtong Fund Management Co., Ltd.
0.8053 %
696,036 0.8053 % 3 M ¥
Yinhua Fund Management Co., Ltd.
0.7953 %
687,357 0.7953 % 3 M ¥
GF Fund Management Co., Ltd.
0.6159 %
532,330 0.6159 % 2 M ¥
Bosera Asset Management Co., Ltd.
0.3952 %
341,587 0.3952 % 2 M ¥
NameEquities%Valuation
Xierong International Development Co. Ltd.
76.23 %
48,630,632 76.23 % 222 M ¥
Yuan Wang
4.171 %
2,660,423 4.171 % 12 M ¥
Shanghai Yuanmeng Enterprise Mgmt Consulting Partnership LP
0.6997 %
446,354 0.6997 % 2 M ¥
Li Zhu
0.2688 %
171,490 0.2688 % 784 570 ¥
Shanghai Yuanli Enterprise Management Partnership LP
0.2144 %
136,748 0.2144 % 625 625 ¥

Company contact information

Shanghai Haoyuan Chemexpress Co. Ltd.

Building 3, Lane 1999 Zhangheng Road

201203, Shanghai

+

http://www.chemexpress.com.cn
address Shanghai Haoyuan Chemexpress Co., Ltd.(688131)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Shanghai Haoyuan Chemexpress Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
32.05
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
SHANGHAI HAOYUAN CHEMEXPRESS CO., LTD. Stock Shanghai Haoyuan Chemexpress Co., Ltd.
-38.44% 69Cr
CSL LIMITED Stock CSL Limited
-1.26% 8.95TCr
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 4.07TCr
BIOGEN INC. Stock Biogen Inc.
-9.06% 3.3TCr
UCB Stock UCB
+55.32% 2.47TCr
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.61% 1.51TCr
INCYTE CORPORATION Stock Incyte Corporation
-9.14% 1.28TCr
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.11% 1.18TCr
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.61% 1.16TCr
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+7.79% 890.22Cr
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 688131 Stock
  4. Company Shanghai Haoyuan Chemexpress Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW